Finding A
Cure For ALS
The Angel Fund supporters make a difference in fighting ALS, and you can be one of them.
Finding A
Cure For ALS
The Angel Fund supporters make a difference in fighting ALS, and you can be one of them.
FACES OF ALS
Every dollar helps in the battle to cure ALS.
BOSTON MARATHON
For ALS
Every dollar helps in the battle to cure ALS.
Harpoon 5 Miler
For ALS
Every dollar helps in the battle to cure ALS.
The Angel Fund for ALS Research
OUR MISSION
The Angel Fund for ALS Research (Angel Fund, Inc.) is committed to accelerating ALS research and turning scientific discovery into effective treatments—and ultimately, a cure.
We believe ALS is not unbeatable—it is underfunded. That belief drives everything we do. Through our fundraising efforts, we provide critical financial support to leading researchers working to better understand ALS, uncover its causes, develop promising therapies, and move discoveries from the laboratory toward treatment.
The Angel Fund receives support through individual and corporate donations, fundraising events, sponsorships, grants, community programs, and the generosity of people who believe that a cure is possible. We work to ensure that the generosity of our supporters directly advances the search for answers, therapies, and a cure with 92% of funds expended going to research.
What makes The Angel Fund different is that ALS is personal to us. Our Board of Directors include individuals and families who have been directly affected by ALS. We know the urgency of this disease, we understand the heartbreak it causes and we understand the urgency because we have witnessed the devastating impact of this disease firsthand.
Since our founding in 1987, we have worked to support the top ALS researchers and innovative research with the goal of moving science forward faster and bringing meaningful treatments to patients.
Veterans Faces of ALS
The Angel Fund supports the brave men and women who have served our country by helping fund critical ALS research focused on military veterans. Veterans are significantly more likely to develop ALS, regardless of when or where they served. Your support will help researchers better understand why this disease impacts veterans at higher rates — and advance efforts to improve treatments, discover prevention strategies, and ultimately find a cure. Stand with our veterans in this fight, just as they once stood for all of us.
Researchers at the UMass Chan Medical School in Worcester have started working with several Veterans, including ALS patient and US Army Veteran, 2nd Lieutenant Liz Fassler who served for two years as a tactical control officer for the Patriots Missiles in the Air Defense Artillery Branch in the Middle East. By working with the researchers, Liz hopes to assist in their efforts to find if there is a correlation between ALS and those who have been deployed.
Angels Over Boston ALS Workshop
The Angel Fund for ALS Research recently brought together leading researchers and clinicians from around the world for its first international conference dedicated to advancing research that will lead to effective treatments—and ultimately a cure—for Amyotrophic Lateral Sclerosis (ALS), more commonly known as Lou Gehrig’s Disease. The conference, Angels Over Boston, focused on emerging therapeutic approaches leading to treatment.
The two-day scientific workshop was attended by internationally recognized ALS researchers and clinicians from the United States, Israel, France, Sweden, Greece and Germany.
The Angel Fund for ALS Research recently presented $400,000 to the Sean M. Healey & AMG Center for ALS to support research into the use of a new technology platform for identifying novel biomarkers. The funds will support Drs. Berry’s research to identify novel biomarkers of ALS onset in genetically at-risk participants from the Dominantly Inherited ALS (DIALS) study. Biosamples will be analyzed using the Nucleic acid-Linked Immuno-Sandwich Assay (NULISA) platform, a new technology that can detect protein biomarkers.
